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1. Introduction 
Cyclic AMP dependent protein kinase was origi- 
nally discovered as the trace endogenous contaminant 
in phosphorylase kinase, that was responsible for 
activation of the latter enzyme following incubation 
with cyclic AMP, ATP and magnesium ions [l] . 
Subsequently, cyclic AMP dependent protein kinase 
was found to regulate the activity of other proteins, 
and it is now firmly established that this enzyme 
mediates most, if not all, of the intracellular actions 
of hormones which work through cyclic AMP, 
according to the following series of reactions [2] : 
raised activated 
hormone -+ cyclic + protein + 
AMP kinase 
phosphorylated ~ physiological 
protein response 
One of the first pieces of evidence which implicated 
cyclic AMP dependent protein kinase in the regulation 
of cellular processes other than glycogen metabolism, 
was the finding that its activity was relatively constant 
over a wide range of mammalian tissues, and was high 
even in those tissues where glycogen metabolism was 
of very minor importance [3]. This initiated the 
search for other physiological substrates for the 
enzyme, and well established examples now include 
histone Hl and L-type pyruvate kinase (liver), 
* This enzyme was previously termed protein phosphatase-III 
[4,6]. The reasons for the change in nomenclature are 
discussed in [7] 
cholesterol esterase (adrenal cortex), triglyceride 
lipase (adipose tissue), troponin-I (cardiac muscle) 
and acetyl CoA carboxylase (mammary gland) [4,5] . 
These findings have raised the question of whether 
the dephosphorylation of each of these proteins is 
catalysed by a single protein phosphatase activity. 
The possibility that this could be so, again relies 
heavily on information available from studies of the 
regulation of glycogen metabolism in skeletal muscle. 
This laboratory has demonstrated that a single major 
enzyme in skeletal muscle, termed protein phos- 
phatase-l*, catalyses each of the dephosphorylations 
which inhibit glycogenolysis or activate glycogen 
synthesis [4,6&g]. It therefore not only reverses the 
phosphorylation of phosphorylase kinase and 
glycogen synthetase catalysed by cyclic AMP depen- 
dent protein kinase but it also reverses the phos- 
phorylation of phosphorylase catalysed by phos- 
phorylase kinase and the phosphorylation of glycogen 
synthetase catalysed by glycogen synthetase kinase-2 
[4,6] i.e. protein kinases whose activities are not 
regulated by cyclic nucleotides. 
The ability of protein phosphatase-1 to catalyse a 
number of functionally related dephosphorylations in 
glycogen metabolism demonstrates that this enzyme 
has a rather broad specificity, and the idea that it 
may dephosphorylate other enzymes in vivo is 
particularly attractive since all interconvertible 
enzymes involved in biodegradative pathways are 
activated by phosphorylation, while all intercon- 
vertible enzymes which catalyse reactions in biosyn- 
thetic pathways are inactivated by phosphorylation 
141. 
The investigation of this possibility has been 
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facilitated by the recent discovery that skeletal 
muscle contains two heat stable proteins, termed 
inhibitor-l and inhibitor-2, which appear to specifi- 
cally inhibit protein phosphatase-1 . The inhibitions 
are reversible and occur with KI values in the nM 
range. Inhibitor-l is only effective after it has been 
phosphorylated by cyclic AMP dependent protein 
kinase [8-lo]. 
In this paper, we have measured the ability of 
mammalian tissue extracts to dephosphorylate muscle 
phosphorylase a, and have tested the susceptibility of 
this activity to inhibition by highly purified prepara- 
tion of inhibitor-l and inhibitor-2. The results 
strongly support the idea of a wider role for this 
enzyme in the regulation of metabolism. 
2. Materials and methods 
2.1. Protein and enzyme preparations 
Phosphorylase b [ 1 l] , phosphorylase kinase [ 121 
and inhibitor-l [lo] were purified to homogeneity 
from rabbit skeletal muscle, and 32P-labelled phos- 
phorylase a (5 X 10’ cpm per pmol) was prepared 
from phosphorylase b using purified phosphorylase 
kinase and [y-32P]ATP [6]. The protein inhibitor of 
cyclic AMP dependent protein kinase was partially 
purified as a byproduct of the purification of 
inhibitor-l [lo] . Inhibitor-2 also copurified through 
the first three steps of this procedure and was then 
further purified by gel filtration on Sephadex G-l 00 
at pH 8.5 and chromatography on DEAE-cellulose at 
pH 5.0. It was enriched 30 OOO-fold over the muscle 
extracts and had a purity of 70-80% (J. G. Foulkes 
and P. Cohen, unpublished work). Protein phosphatase-I 
was purified 300400 fold from rabbit skeletal muscle 
16,131. 
2.2. Preparation of tissue extracts 
New Zealand White rabbits were killed by an 
intravenous injection of nembutal, exsanguinated, 
and the skeletal muscle and other tissues were excised 
and chilled in ice. The skeletal muscle was minced 
and homogenised in a Waring Blender with 2.0 vol. of 
4.0 mM EDTA/15 mM mercaptoethanol pH 7.0. The 
other tissues were chopped finely with scissors and 
homogenized in an ‘Ultra-Turrex’ homogeniser 
(Janke and Kunkel) using 2.5 vol. of the same buffer. 
The homogenates were centrifuged at 10 000 X g for 
30 min and passed through glass wool to remove fat. 
2.3. Measurement of phosphorylase, phosphorylase 
kinase and cyclic AMPdependent protein kinase 
activities in tissue extracts 
Phosphorylase kinase was assayed at pH 8.6 [ 121 
and phosphorylase in the direction of glycogen syn- 
thesis with 5’-AMP [ 141. Cyclic AMP dependent 
protein kinase was assayed using a mixed histone 
substrate (Sigma type HA) [8] . The control incuba- 
tions were carried out in the presence of a large 
excess of the protein kinase inhibitor. 
2.4. Measurement of phosphorylase phosphatase 
activity in tissue extracts 
Tissue extracts contain low molecular weight 
compounds which are powerful inhibitors of protein 
phosphatase-1 [lo] . In order to obtain reliable 
estimates of the activity, extracts (2.0 ml) were there- 
fore passed through a column of Sephadex G-25 
superfine (15 X 1 cm) equilibrated in 50 mM Tris- 
HCl/l .O mM EDTAil 5 mM mercaptoethanol, pH 7.0 
prior to assay. The assays were also carried out at a 
final dilution over the tissue extracts of at least 
1:60, this dilution being sufficient to eliminate 
inhibition of protein phosphatase-1 by high molecular 
weight compounds present in each extract. 
Phosphorylase phosphatase activity was assayed in 
the presence and absence of inhibitor-l and inhibitor-2 
as described previously [6,8,10] . Manganese chloride 
was omitted from all assays. 
3. Results 
3.1. Enzyme activity measurements in tissue extracts 
The phosphorylase, phosphorylase kinase, phos- 
phorylase phosphatase and cyclic AMP dependent 
protein kinase activities are given in table 1. Phos- 
phorylase and phosphorylase kinase were only 
measured in tissue extracts where the phosphorylase 
was of the ‘muscle’ or ‘brain’ type, and not the ‘liver’ 
type. The activities of the b-form and a-form of these 
two isoenzymes are very similar when assays are 
carried out in the presence of 5’-AMP [ 161. The 
activities should therefore measure the relative con- 
centration of phosphorylase in these tissues. The 
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Table 1 
Relative specific activities of phosphorylase, phosphorylase kinase, phosphorylase phosphatase 
and cyclic AMP dependent protein kinase in rabbit tissue extracts 
Tissue Phosphorylase Phosphorylase 
kinase 
Phosphorylase 
phosphatase 
Cyclic AMP 
dependent 
protein kinase 
Skeletal muscle 100 100 100 100 
Cardiac muscle 10 5.3 47 120 
Brain 5.6 2.3 55 250 
Mammary glanda 2.3 2.2 45 170 
Adipose tissueb 0.5 0.3 52 430 
Liver 37 
Kidney 47 
Lung 45 
a During peak lactation 
b Supra-renal adipose tissue 
The results are the average of values from at least three different extracts and are expressed 
relative to skeletal muscle = 100. Protein concentrations were determined by the method of 
Bradford [ 151. The specific activities in skeletal muscle were: phosphorylase (5.6 U/mg), phos- 
phorylase kinase (84 U/mg), phosphorylase phosphatase (0.96 U/mg), cyclic AMP dependent 
protein kinase (0.08 U/mg). One unit of activity is the number of nmol (phosphorylase 
kinase, phosphorylase phosphatase, cyclic AMP dependent protein kinase) or pmol (phos- 
phorylase) of product produced per min 
specific activities of phosphorylase and phosphorylase 
kinase were found to vary 200-300 fold in the five 
tissues studied (table 2), but the activity ratio phos- 
phorylase/phosphorylase kinase was rather constant. 
In contrast, the specific activity of phosphorylase 
phosphatase only varied 2-3 fold, while the activity 
ratio phosphorylase/phosphorylase phosphatase 
varied by lOO-fold. The distribution of phosphorylase 
phosphatase activity did not therefore parallel that of 
phosphorylase and phosphorylase kinase. In this 
respect it resembled cyclic AMP dependent protein 
kinase, which was high in tissues where the glycogen- 
olytic enzymes were very low (table 1). 
3.2. Influence of inhibitor-l and inhibitor-2 on the 
phosphorylase phosphatase activity of tissue 
extracts 
These two proteins inhibited the phosphorylase 
phosphatase activity of all tissue extracts examined 
(fig. 1). One unit of inhibitor- 1, which corresponds 
to a concentration of only 5 nM or 0.1 pg/ml in the 
assay, inhibited phosphorylase phosphatase activity in 
the tissue extracts by 3046%. One unit ofinhibitor-2, 
corresponding to a concentration of about 12 nM or 
August 1978 
Table 2 
Effect of inhibitor-l and inhibitor-2 (10 units) on the activity 
of phosphorylase phosphatase in rabbit tissue extracts 
Tissue extract Inhibition (%) 
Inhibitor-l Inhibitor-2 
Skeletal muscle 68 78 
Mammary glanda 62 69 
Cardiac muscle 63 73 
Liver 57 66 
Brain 53 64 
Kidney 66 62 
Lung 62 72 
Adipose tissueb 71 85 
Protein Phosphatase-1” 80 90 
a During peak lactation 
b Supra-renal adipose tissue 
’ Purified 300-fold from skeletal muscle [6,13] 
The assays contained 0.01 i 0.004 U of phosphorylase phos- 
phatase One unit of inhibitor is that amount which inhibits 
0.02 U of partially purified protein phosphatase-1 by 50% in 
the standard assay. The results with each tissue are the 
average of experiments carried out with three different 
extracts 
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Fig.1. Influence of inhibitor-l (A) and inhibitor-2 (B) on the phosphorylase phosphatase activity of rabbit tissue extracts. Each 
extract was suitably diluted so that the assays contained 0.01 * 0.004 units of phosphorylase phosphatase. One unit of inhibitor 
is that amount which inhibits 0.02 units of partially purified protein phosphatase-1 by 50% in the standard assay. Symbols: 
0, brain; o, liver; v, heart; X mammary gland; v skeletal muscle. 
0.4 pg/ml in the assay, inhibited the activities by 
27-52%. 
The inhibition of phosphorylase phosphatase in 
the tissue extracts was a little less than with partially 
purified protein phosphatase-1 (table 2). This dis- 
crepancy and the slight variation from tissue to tissue, 
could be explained in a number of ways. For example, 
inhibitor-l and inhibitor-2 may interact with proteins 
other than protein phosphatase-1 . Alternatively, 
tissue extracts may contain protein phosphatases 
which have phosphorylase phosphatase activity, but 
are unaffected by inhibitor-l or inhibitor-2. This is 
certainly the case in skeletal muscle, which contains 
two additional protein phosphatases which have 
slight phosphorylase phosphatase activity and are 
insensitive to the inhibitor proteins [6,8]. 
4. Discussion 
The results presented in this paper have shown 
that the phosphorylase phosphatase activity of rabbit 
tissues is remarkably constant even in tissues where 
the phosphorylase and phosphorylase kinase activities 
are very low (table 1). Furthermore these activities are 
extremely sensitive to inhibitor-l and inhibitor-2, 
which inhibit protein phosphatase-1 specifically. 
This information allows the following inferences to 
be made. Firstly, protein phosphatase-1 or a closely 
analogous protein is present at a very similar con- 
centration in all of these tissues. Secondly, this 
enzyme is likely to dephosphorylate protein substrates 
other than those involved in glycogen metabolism. 
Severson et al. [ 171 have stated that a highly purified 
preparation of phosphorylase phosphatase from rabbit 
liver was able to inactivate hormone sensitive tri- 
glyceride lipase from chicken adipose tissue, which had 
been activated by cyclic AMP dependent protein kinase. 
Ingebritsen et al. [ 181 have also reported that liver 
microsomal hydroxymethylglutaryl CoA reductase 
which had been inactivated by incubation with ATP 
and magnesium ions could be reactivated by a protein 
phosphatase preparation, which appeared to copurify 
with liver phosphorylase phosphatase. Similarly, 
protein phosphatase-1 from skeletal muscle has been 
found to catalyse the dephosphorylation of acetyl 
CoA carboxylase from mammary gland, which 
has been phosphorylated by either cyclic AMP 
dependent protein kinase or by acetyl CoA carboxyl- 
ase kinase-2( [S] , D-G. Hardie and P. Cohen, unpublished 
experiments from this laboratory). These observations 
strengthen the view that protein phosphatase-1 may 
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have a number of physiological substrates, and the 
identification of more of these proteins should help 
in the development of an integrated view of the 
regulation of intermediary metabolism in mammalian 
tissues. 
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